Evis Harja
Impact in
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 9
-
- S100 Proteins and Annexins 3
- Protein Kinase Regulation and GTPase Signaling 3
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Ann Marie Schmidt (13 shared papers)Barry I. Hudson (7 shared papers)Anastasia Z. Kalea (4 shared papers)Yan Lü (5 shared papers)Shi Fang Yan (3 shared papers)Loredana Bucciarelli (3 shared papers)Maria Arriero (3 shared papers)Éric Boulanger (1 shared paper)
- Journals
- The FASEB Journal (3 papers)Atherosclerosis (3 papers)Circulation Research (2 papers)Journal of Biological Chemistry (2 papers)Journal of Thrombosis and Haemostasis (1 paper)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Evis Harja
19 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 88
- Clinical Biochemistry 1.0k
- Endocrinology, Diabetes and Metabolism 358
- Periodontics 73
- Immunology 309
- Nephrology 88
Countries citing papers authored by Evis Harja
This map shows the geographic impact of Evis Harja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evis Harja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evis Harja more than expected).
Fields of papers citing papers by Evis Harja
This network shows the impact of papers produced by Evis Harja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evis Harja. The network helps show where Evis Harja may publish in the future.
Co-authors
The 25 scholars most cited alongside Evis Harja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 319 | |
| 2 | 2008 | 318 | |
| 3 | 2008 | 304 | |
| 4 | 2006 | 213 | |
| 5 | 2005 | 192 | |
| 6 | 2003 | 128 | |
| 7 | 2007 | 106 | |
| 8 | 2006 | 103 | |
| 9 | 2006 | 64 | |
| 10 | 2008 | 63 | |
| 11 | 2010 | 36 | |
| 12 | 2005 | 36 | |
| 13 | 2016 | 32 | |
| 14 | 2008 | 30 | |
| 15 | 2016 | 28 | |
| 16 | 2013 | 24 | |
| 17 | 2005 | 21 | |
| 18 | 2010 | 16 | |
| 19 | 2014 | 1 | |
| 20 | 2006 | 0 |
About Evis Harja
Evis Harja is a scholar working on Clinical Biochemistry, Molecular Biology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (9 papers), S100 Proteins and Annexins (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Clinical Biochemistry (1.0k citations), Endocrinology, Diabetes and Metabolism (358 citations), Periodontics (73 citations), Immunology (309 citations) and Nephrology (88 citations). Evis Harja has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Ann Marie Schmidt, Barry I. Hudson, Anastasia Z. Kalea, Yan Lü, Shi Fang Yan, Loredana Bucciarelli, Maria Arriero, Éric Boulanger, Vivette D. D’Agati and María del Mar Arriero. Their work appears in journals such as The FASEB Journal, Atherosclerosis, Circulation Research, Journal of Biological Chemistry and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.